Company profile: Ostoform
1.1 - Company Overview
Company description
- Provider of ostomy skin health devices as a spin-out medical device company from the University of Limerick, Ireland, offering the Ostoform Seal with FLOWASSIST to direct high liquid stoma output away from skin into the pouch to help reduce skin complications and leakage, and the FLOWASSIST 2-Piece Pouch with baseplate-integrated technology for easier management of problematic stomas, durability, and security.
Products and services
- FLOWASSIST 2-Piece Pouch: A modular ostomy pouching system incorporating FLOWASSIST technology into its baseplate to ease management of problematic stomas while delivering durable, secure wear
- Ostoform Seal with FLOWASSIST: An industrial-grade stoma seal that directs high liquid output away from skin into the pouch via FLOWASSIST, aiming to reduce skin complications and leakage
- Patented Ostomy Skin Health Technologies: A patented portfolio in ostomy skin health developed by a University of Limerick spin-out, with potential to scale toward global leadership in the field
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ostoform
Prometheus Laboratories
HQ: United States
Website
- Description: Provider of precision gastroenterology diagnostics and tools, including: PredictrPK precision-guided dosing tests for infliximab and adalimumab using serology markers, patient variables, current dosing and machine-learning to optimize biologic therapy for IBD; Anser therapeutic drug monitoring measuring drug levels and antibodies; Monitr disease monitoring for IBD; and CDPATH prognostic tool predicting Crohn's complications risk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prometheus Laboratories company profile →
NuvoMed
HQ: United States
Website
- Description: Provider of a patented, disposable medical device (DisImpactor) for safe, fast, and effective relief of fecal impaction, delivering maximum comfort and clinical efficacy. Committed to improving this unpleasant procedure for patients and physicians and to technologies that enhance patient outcomes and healthcare delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuvoMed company profile →
SafeHeal
HQ: France
Website
- Description: Provider of Colovac, an innovative colorectal anastomosis protection device designed to reduce contact of fecal content at the anastomotic site following colorectal surgery, intended to eliminate the need for a diverting ostomy and reduce anastomotic complications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SafeHeal company profile →
LAT Pharma
HQ: United States
Website
- Description: Provider of discovery, development, and commercialization of novel drug therapies for people with advanced liver cirrhosis and its life-threatening complications, initially targeting ascites.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LAT Pharma company profile →
EndoTools Therapeutics
HQ: Belgium
Website
- Description: Provider of medical devices enabling therapeutic interventions for gastroenterologists, including the endomina system for incisionless endoscopic suturing of gastric conditions and the TAPES suturing unit for tissue piercing and approximation, plus professional education programs to master endoscopic gastroplasty; also developing a catheter to add therapeutic channels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EndoTools Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ostoform
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ostoform
2.2 - Growth funds investing in similar companies to Ostoform
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ostoform
4.2 - Public trading comparable groups for Ostoform
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →